Bangladesh · Delayed Price · Currency is BDT Orion Infusion Statistics
Total Valuation
Orion Infusion has a market cap or net worth of BDT 6.31 billion. The enterprise value is 6.60 billion.
| Market Cap | 6.31B |
| Enterprise Value | 6.60B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Dec 2, 2025 |
Share Statistics
Orion Infusion has 20.36 million shares outstanding. The number of shares has increased by 0.39% in one year.
| Current Share Class | 20.36M |
| Shares Outstanding | 20.36M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | +0.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 178.21.
| PE Ratio | 178.21 |
| Forward PE | n/a |
| PS Ratio | 9.75 |
| PB Ratio | 19.13 |
| P/TBV Ratio | 19.13 |
| P/FCF Ratio | 95.69 |
| P/OCF Ratio | 94.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 72.69, with an EV/FCF ratio of 99.97.
| EV / Earnings | 185.73 |
| EV / Sales | 10.19 |
| EV / EBITDA | 72.69 |
| EV / EBIT | 89.40 |
| EV / FCF | 99.97 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.90.
| Current Ratio | 0.97 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | 3.26 |
| Debt / FCF | 4.48 |
| Interest Coverage | 2.12 |
Financial Efficiency
Return on equity (ROE) is 10.93% and return on invested capital (ROIC) is 9.73%.
| Return on Equity (ROE) | 10.93% |
| Return on Assets (ROA) | 5.47% |
| Return on Invested Capital (ROIC) | 9.73% |
| Return on Capital Employed (ROCE) | 20.41% |
| Weighted Average Cost of Capital (WACC) | -4.38% |
| Revenue Per Employee | 1.15M |
| Profits Per Employee | 63,077 |
| Employee Count | 563 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.79 |
Taxes
In the past 12 months, Orion Infusion has paid 9.02 million in taxes.
| Income Tax | 9.02M |
| Effective Tax Rate | 20.26% |
Stock Price Statistics
The stock price has decreased by -14.97% in the last 52 weeks. The beta is -1.69, so Orion Infusion's price volatility has been lower than the market average.
| Beta (5Y) | -1.69 |
| 52-Week Price Change | -14.97% |
| 50-Day Moving Average | 329.28 |
| 200-Day Moving Average | 397.66 |
| Relative Strength Index (RSI) | 41.47 |
| Average Volume (20 Days) | 192,638 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Orion Infusion had revenue of BDT 647.55 million and earned 35.51 million in profits. Earnings per share was 1.74.
| Revenue | 647.55M |
| Gross Profit | 267.40M |
| Operating Income | 73.77M |
| Pretax Income | 44.53M |
| Net Income | 35.51M |
| EBITDA | 85.65M |
| EBIT | 73.77M |
| Earnings Per Share (EPS) | 1.74 |
Balance Sheet
The company has 13.52 million in cash and 295.63 million in debt, with a net cash position of -282.11 million or -13.86 per share.
| Cash & Cash Equivalents | 13.52M |
| Total Debt | 295.63M |
| Net Cash | -282.11M |
| Net Cash Per Share | -13.86 |
| Equity (Book Value) | 330.07M |
| Book Value Per Share | 16.11 |
| Working Capital | -14.00M |
Cash Flow
In the last 12 months, operating cash flow was 66.71 million and capital expenditures -730,515, giving a free cash flow of 65.98 million.
| Operating Cash Flow | 66.71M |
| Capital Expenditures | -730,515 |
| Depreciation & Amortization | 11.87M |
| Net Borrowing | -29.81M |
| Free Cash Flow | 65.98M |
| FCF Per Share | 3.24 |
Margins
Gross margin is 41.29%, with operating and profit margins of 11.39% and 5.48%.
| Gross Margin | 41.29% |
| Operating Margin | 11.39% |
| Pretax Margin | 6.88% |
| Profit Margin | 5.48% |
| EBITDA Margin | 13.23% |
| EBIT Margin | 11.39% |
| FCF Margin | 10.19% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.64%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | 66.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 128.43% |
| Buyback Yield | -0.39% |
| Shareholder Yield | 0.26% |
| Earnings Yield | 0.56% |
| FCF Yield | 1.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.
| Last Split Date | Dec 4, 2011 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |